Received May 29, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | Z012402 | — |
No side effects or symptoms reported. No Additional AE; a 7 year old male received GARDASIL 9 administration on 05/27/2026; This spontaneous report was received from a medical assistant and refers to a 7-year-old male patient. The patient's medical history, concurrent conditions, past medications and concomitant medications were not reported. On 27-May-2026, the patient was vaccinated with Human Papillomavirus 9-Valent Vaccine, Recombinant (GARDASIL 9) suspension for injection in pre-filled syringe, at total dose of 0.5 ml, lot# Z012402, expiration date: 16-Sep-2027 (dose number, route of administration and anatomical location were not reported), for prophylaxis (Product administered to patient of inappropriate age). No side effects or symptoms and no additional adverse event were reported.